JERUSALEM--(BUSINESS WIRE)--BioLineRx Ltd. (TASE:BLRX), Israel’s leading drug development company, announced today that Tamar Howson, Gil Bianco and Ilan Leviteh have been appointed to the Company's board of directors.
Ms. Howson brings to BioLineRx more than 20 years of pharmaceutical and biotech industry experience. Ms. Howson currently serves as executive vice president of business development at Lexicon Pharmaceuticals, which she joined after six years as senior vice president of corporate and business development and member of the executive committee of Bristol-Myers Squibb Company. Between 1991 and 2000 Ms. Howson managed the corporate and business development functions of SR One, a $100MM venture fund, at SmithKline Beecham.
